Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab

TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study.

(2017) Janet E. Murphy et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses

(2016) Siobhan Conroy et al.   JOURNAL OF NEURO-ONCOLOGY

Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients

(2016) Antoine Kourilsky et al.   JOURNAL OF NEUROLOGY

Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment

(2016) Tiffany T. Liu et al.   NEURO-ONCOLOGY

Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

(2015) R. R. McKay et al.   CLINICAL CANCER RESEARCH

Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma

(2015) E. Januel et al.   EUROPEAN JOURNAL OF NEUROLOGY

Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

(2015) Christine Lu-Emerson et al.   JOURNAL OF CLINICAL ONCOLOGY

Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients

(2015) Antonio Facciorusso et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma

(2015) Victor A. Levin et al.   JOURNAL OF NEURO-ONCOLOGY

Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

(2014) Rakesh K. Jain   CANCER CELL

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combining two strategies to improve perfusion and drug delivery in solid tumors

(2013) T. Stylianopoulos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

(2013) Vikash P. Chauhan et al.   Nature Communications

Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs

(2012) Giuseppe Lombardi et al.   ANTI-CANCER DRUGS

Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients

(2012) A. F. Carpentier et al.   EUROPEAN JOURNAL OF NEUROLOGY

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

(2012) Y. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts

(2011) Veronique Lorgis et al.   JOURNAL OF NEURO-ONCOLOGY

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

(2011) B. Diop-Frimpong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA